Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to ...
Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.
By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...
Preclinical study findings point to new possibilities for strategies for treating metastatic TNBC patients for whom there are no specific therapies.
The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology to include ...
A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.
Verywell Health on MSN
What you need to know about triple-negative breast cancer with chemo resistance
Medically reviewed by Marla Anderson, MD Key Takeaways Triple-negative breast cancer is aggressive and often resists ...
This new article publication from Acta Pharmaceutica Sinica B, discusses DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast ...
DATROWAY Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic TNBC Who Are Not Candidates ...
Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks estrogen, progesterone, and HER2 receptors ...
The FDA accepted a supplemental biologics license application and granted priority review for Datroway for adults ...
5don MSN
New genetic tools offer more accurate breast cancer prediction for women of African ancestry
Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results